FTSE MIB
33.922,16 +40,66 (+0,12%) Dow Jones
37.986,40 +211,02 (+0,56%) Nasdaq
15.282,01 -319,49 (-2,05%) Nikkei 225
37.068,35 -1.011,35 (-2,66%) Petrolio
83,22 +0,49 (+0,59%) Bitcoin EUR
60.249,65 +699,06 (+1,17%)
Accolade, Inc. (ACCD)
Dopo ore:
| Chiusura precedente | 9,17 |
| Aperto | 9,08 |
| Denaro | 9,13 x 200 |
| Lettera | 9,19 x 200 |
| Min-Max giorno | 8,83 - 9,47 |
| Intervallo di 52 settimane | 6,33 - 17,00 |
| Volume | |
| Media Volume | 603.830 |
| Capitalizzazione | 706,731M |
| Beta (5 anni mensile) | 2,08 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -1,62 |
| Prossima data utili | 25 apr 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 15,07 |
GlobeNewswireAccolade Announces Results for Fiscal Second Quarter 2024
SEATTLE, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter ended August 31, 2023. “We are halfway through the 2024 fiscal year and the demand environment for our solutions remains strong. Accolade continues to lay the foundation to build a lasting, scalable business that will improve people’s lives and fundamentally change the way healthcare is experienced in this country. Accolade's unique combination of advocacy and
- GlobeNewswire
Accolade to Announce Fiscal Second Quarter 2024 Financial Results
SEATTLE, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will release fiscal second quarter 2024 financial results on Wednesday, October 4, 2023, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call Details To Listen via Telephone: Pre-registration is required by the conference call operator. Please pre-r
- GlobeNewswire
CORRECTING and REPLACING -- Accolade To Present at Upcoming Investor Conferences
SEATTLE, Sept. 06, 2023 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Sept. 5, 2023 by Accolade, Inc. (NASDAQ: ACCD), please note that in the second bullet, the time of the Morgan Stanley presentation should be 1:35 pm ET, not 8:10 am ET as previously stated. The corrected release follows: Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the following upcoming investor conferences: 2023 Wells
